As of 2025-07-09, the Relative Valuation of Oncodesign SA (ALONC.PA) is (3.68) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 14.42 EUR, the upside of Oncodesign SA based on Relative Valuation is -125.6%.
The range of the Relative Valuation is (5.62) - 3.44 EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.3x - 17.0x | 11.6x |
| Forward P/E multiples | 28.0x - 37.1x | 32.6x |
| Fair Price | (5.62) - 3.44 | (3.68) |
| Upside | -139.0% - -76.1% | -125.6% |
| Date | P/E |